Jindu Biosciences unveils GeneLLM and pushes AI deeper into life science labs
Jindu Biosciences, a Chinese startup founded by four Oxford-linked returnees, has introduced GeneLLM, a multi-omics foundation model the company says has appeared in Nature Communications and Advanced Science. The model is described as the first multi-omics large model to pretrain directly on raw omics data, including transcriptomic, proteomic and metabolomic inputs, rather than relying first on gene annotations or manually defined labels. Jindu says GeneLLM has completed pretraining at 1.5 billion parameters on 3.5 trillion base sequences, while an XLarge version has reached 30 billion parameters. The company is also building a broader AI-for-Science stack around the model. Its BioFord Harness system is designed to connect AI reasoning with physical laboratory execution, translating scientific intent into machine instructions, scheduling heterogeneous instruments and feeding experiment outputs back into the next model and experiment cycle. On top of that, Jindu has rolled out BioFord Agent, a platform built around five agents for literature review, experiment design, scientific reasoning, lab scheduling and data analysis. Founder and CEO Jin Yongcheng said the challenge in bioscience is not simply scaling models or data, but solving the gap between computation and real-world experimental execution. The company says its physical AI research platform has already been deployed at some well-known universities in China and has reduced research cycles from months to one week.








